Trinity Biotech holds annual general meeting
Bitget2026/10/05 11:23Trinity Biotech held its annual general meeting on Sept. 30, 2026, with shareholders backing all items put to a vote. Grant Thornton’s appointment as statutory auditor was approved, covering service through the next annual general meeting when accounts are presented. The board received authority to set the statutory auditor’s remuneration; the filing does not confirm any fee decision has been made. Shareholders also approved the re-appointment of Dr Andrew Omidvar as a director; the filing does not address any subsequent board actions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554855-26-002068), on October 05, 2026, and is solely responsible for the information contained therein.
- Trinity Biotech held its annual general meeting on Sept. 30, 2026, with shareholders backing all items put to a vote.
- Grant Thornton’s appointment as statutory auditor was approved, covering service through the next annual general meeting when accounts are presented.
- The board received authority to set the statutory auditor’s remuneration; the filing does not confirm any fee decision has been made.
- Shareholders also approved the re-appointment of Dr Andrew Omidvar as a director; the filing does not address any subsequent board actions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
2.0%: Germany's Industrial Production rises faster-than-expected in August
Middle Eastern oil flow restored to about 80% of pre-war levels; Shell CEO Sawan says energy security is the cornerstone of national security.
According to reports, Shell (SHEL.US) CEO Wael Sawan said on Tuesday that Middle East oil flows have recovered to about 80% of pre-war levels.
BUZZ-Australia's Kelsian shares rise as asset sale triggers Morningstar's cautious optimism
Latest developments on October 7th – Kelsian Group (KLS.AX) shares briefly rose 1% to A$3.93 before narrowing gains to 0.3% by midday in Sydney. Morningstar holds a positive view on the transport operator’s recently announced A$150 million (US$104.76 million) sale of travel assets in mid-September. The investment research firm noted that this divestment relieves the transportation and travel operator from reliance on discretionary-spending businesses such as resorts, cruises, and tours. It also stated that the sale enables management to focus more on core operations and moderately reduces capital intensity. However, Morningstar pointed out that the sale means profits from the marine segment will still be "discretionary in nature." It added that the sale will leave the company’s earnings mainly dependent on its US interstate coach business, which is characterized by short-term contracts without cost-adjustment mechanisms and serves highly volatile sectors such as technology, oil, and gas. Year to date, the share price is down 8.2%. (US$1 = A$1.4318) (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Automated translation may be inaccurate or may not completely reflect the required context; Reuters does not guarantee the accuracy of translated texts, which are provided solely for reader convenience. Reuters is not responsible for any harm or loss arising from the use of automatic translation.)
Crypto prices
More
